Korea's listed drug companies witnessed a sales inch up last year from a year earlier, but fell short of reaping more profits than the previous year, data showed Wednesday.
Sales by 50 listed firms rose 1.2 percent to 10.1 trillion won ($1.4 million) in the fiscal year 2012 from a year earlier, according to Yakup.com, a pharmaceutical information provider.
Their operating profit per capit...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.